본문 바로가기
KERD
논문KCI 등재

Effects of Antiretroviral Therapy on the Survival of Human Immunodeficiency Virus-positive Adult Patients in Andhra Pradesh, India: A Retrospective Cohort Study, 2007-2013

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objectives: The survival outcomes of antiretroviral treatment (ART) programs have not been systematically evaluated at the state level in India. This retrospective study assessed the survival rates and factors associated with survival among adult human immunodeficiency virus (HIV)-infected patients in Andhra Pradesh, India. Methods: The present study used data from 139 679 HIV patients aged ≥15 years on ART who were registered from 2007 to 2011 and were followed up through December 2013. The primary end point was death of the patient. Mortality densities (per 1000 person-years) were calculated. Kaplan-Meier and Cox-regression models were used to estimate survival and explore the factors associated with survival. Results: The overall median follow-up time was 16.0 months (2.0 months for the deceased and 14.0 months for those lost to follow-up). Approximately 13.2% of those newly initiated on ART died during follow-up. Of those deaths, 56% occurred in the first three months. The crude mortality rate was 80.9 per 1000 person-years at risk. The CD4 count (adjusted hazard ratio [aHR],4.88; 95% confidence interval [CI], 4.36 to 5.46 for <100 cells/mm3 vs. >350 cells/mm3), functional status (aHR, 3.05; 95% CI, 2.82 to 3.30 for bedridden vs. normal), and body weight (aHR, 3.69; 95% CI, 3.42 to 3.97 for <45 kg vs. >60 kg) were strongly associated with the survival of HIV patients. Conclusions: The study findings revealed that high mortality was observed within the first three months of ART initiation. Patients with poor baseline clinical characteristics had a higher risk of mortality. Expanded testing and counseling should be encouraged, with the goal of ensuring early enrollment into the program followed by the initiation of ART in HIV-infected patients.

Abstract

Objectives: The survival outcomes of antiretroviral treatment (ART) programs have not been systematically evaluated at the state level in India. This retrospective study assessed the survival rates and factors associated with survival among adult human immunodeficiency virus (HIV)-infected patients in Andhra Pradesh, India. Methods: The present study used data from 139 679 HIV patients aged ≥15 years on ART who were registered from 2007 to 2011 and were followed up through December 2013. The primary end point was death of the patient. Mortality densities (per 1000 person-years) were calculated. Kaplan-Meier and Cox-regression models were used to estimate survival and explore the factors associated with survival. Results: The overall median follow-up time was 16.0 months (2.0 months for the deceased and 14.0 months for those lost to follow-up). Approximately 13.2% of those newly initiated on ART died during follow-up. Of those deaths, 56% occurred in the first three months. The crude mortality rate was 80.9 per 1000 person-years at risk. The CD4 count (adjusted hazard ratio [aHR],4.88; 95% confidence interval [CI], 4.36 to 5.46 for <100 cells/mm3 vs. >350 cells/mm3), functional status (aHR, 3.05; 95% CI, 2.82 to 3.30 for bedridden vs. normal), and body weight (aHR, 3.69; 95% CI, 3.42 to 3.97 for <45 kg vs. >60 kg) were strongly associated with the survival of HIV patients. Conclusions: The study findings revealed that high mortality was observed within the first three months of ART initiation. Patients with poor baseline clinical characteristics had a higher risk of mortality. Expanded testing and counseling should be encouraged, with the goal of ensuring early enrollment into the program followed by the initiation of ART in HIV-infected patients.

참고문헌 (33)

  1. "UNAIDS world AIDS day report 2012" (2016)[URL]
  2. "National AIDS Control Organization" (2012)[URL]
  3. Bhatta L, "Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006-2011", BMC Infect Dis, 13, pp.604~ (2013)
  4. Mojumdar K, "Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population", BMC Public Health, 10, pp.416~ (2010)
  5. Egger M, "Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies", Lancet, 360(9327), pp.119~129 (2002)
  6. Mocroft A, "Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group", Lancet, 352(9142), pp.1725~1730 (1998)
  7. "‘3 by 5’ Progress report" (2004)[URL]
  8. "UNAIDS 2011 World AIDS Day report" (2011)[URL]
  9. "Annual report 2015-16" (2015)[URL]
  10. Vella S, "The history of antiretroviral therapy and of its implementation in resource-limited areas of the world", AIDS, 26(10), pp.1231~1241 (2012)
  11. "Antiretroviral therapy (ART) coverage among all age groups"[URL]
  12. Chakravarty J, "Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: a prospective study", Indian J Med Res, 140(4), pp.491~500 (2014)
  13. Rai S, "Adherence to antiretroviral therapy and its effect on survival of HIV-infected individuals in Jharkhand, India", PLoS One, 8(6), pp.e66860~ (2013)
  14. Ryavanki SP, "General profile and survival probabilities of HIV patients registered at anti retroviral therapy (ART) centre, New Civil Hospital, Surat, Gujarat", Natl J Community Med, 4(2), pp.201~207 (2013)
  15. Bachani D, "Two-year treatment outcomes of patients enrolled in India’s national first-line antiretroviral therapy programme", Natl Med J India, 23(1), pp.7~12 (2010)
  16. "Ministry of Health and Family Welfare" (2013)[URL]
  17. "Ministry of Health and Family Welfare" (2009)[URL]
  18. "Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis" (2007)[URL]
  19. Mishra BN, "The epidemiology of opportunistic infections in HIV", AIDS cases in Nepal, 2009, pp.40(1-2), 96~100
  20. Hasse B, "Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study", Clin Infect Dis, 53(11), pp.1130~1139 (2011)
  21. Alemu AW, "Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia", Glob Health Action, 3, pp.5398~ (2010)
  22. Deuba K, "Psychosocial health problems associated with increased HIV risk behavior among men who have sex with men in Nepal: a cross-sectional survey", PLoS One, 8(3), pp.e58099~ (2013)
  23. Jerene D, "Predictors of early death in a cohort of Ethiopian patients treated with HAART", BMC Infect Dis, 6, pp.136~ (2006)
  24. Mageda K, "High initial HIV", AIDS-related mortality and -its predictors among patients on antiretroviral therapy in the Kagera region of Tanzania: a five-year retrospective cohort study, 2012, pp.2012, 843598~
  25. Sieleunou I, "Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon", Trop Med Int Health, 14(1), pp.36~43 (2009)
  26. Bajpai RC, "Demographic correlates of survival in adult HIV patients registered at ART centers in Andhra Pradesh, India: a retrospective cohort study", Public Health Res, 4(1), pp.31~38 (2014)
  27. Johannessen A, "Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania", BMC Infect Dis, 8, pp.52~ (2008)
  28. Alibhai A, "Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda", Int J Womens Health, 2, pp.45~52 (2010)
  29. Shafique N, "Preventing mother-to-child HIV transmission through community-based approach in Nepal", Proceedings of AIDS 2012: XIX International AIDS Conference (2012), International AIDS Society
  30. "Latent tuberculosis infection: a guide for primary health care providers"[URL]
  31. Biadgilign S, "Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study", AIDS Res Ther, 9(1), pp.15~ (2012)
  32. Kee MK, "Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis", BMC Infect Dis, 9, pp.128~ (2009)
  33. Brinkhof MW, "Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis", PLoS One, 4(6), pp.e5790~ (2009)

관련 논문AI추천

Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort studyErdaw Tachbele, Gobena Ameni한국역학회 · Epidemiology and Health2016 · 제38권 Rapid Antiretroviral Therapy Initiation Reduces Mortality Among People Living With HIV in Indonesia: A Retrospective Observational StudyHendarwan Harimat, Lisdawati Vivi, Mauleti Ifael Yerosias, Mulyati Sri, Saptarini Ika, Syamsuridzal Djati Prasetio, Wibisana Krishna Adi대한예방의학회 · 예방의학회지2025 · 제58권 제4호Survival Trend of HIV/AIDS Patients Starting Antiretroviral Therapy in South Korea between 2001 and 2015기미경, 김민자, 김상일, 김수민, 김신우, 김용찬, 김효열, 박대원, 송준영, 안진영, 유명수, 최보율, 최윤수, 최준용, 최희정, 한명국연세대학교의과대학 · Yonsei Medical Journal2020 · 제61권 제8호Life expectancy of HIV-positive patients after diagnosis in Iran from 1986 to 2016: a retrospective cohort study at national and sub-national levelsMohammad Mirzaei, Younes Mohammadi한국역학회 · Epidemiology and Health2018 · 제40권 Spatial inequalities and predictors of HIV/AIDS mortality risk in Hamadan, Iran: a retrospective cohort studyAmir Kavousi, Somayeh Momenyan한국역학회 · Epidemiology and Health2018 · 제40권 Rate of and Risk Factors for Loss to Follow Up in HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study성혜, 김상일, 김신우, 김윤정, 박대원, 송준영, Choi Bo Youl, Choi Jun-Yong, Choi Yunsu, Kim Jung Ho, Kim Minjeong, Park Boyoung대한감염학회 · Infection and Chemotherapy2023 · 제55권 제1호

이 간행물의 다른 논문 (5건)